Analyst Price Target is $8.33
▲ +140.15% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for AbCellera Biologics in the last 3 months. The average price target is $8.33, with a high forecast of $10.00 and a low forecast of $5.00. The average price target represents a 140.15% upside from the last price of $3.47.
Current Consensus is
Moderate Buy
The current consensus among 4 polled investment analysts is to moderate buy stock in AbCellera Biologics. This rating has held steady since July 2024, when it changed from a Buy consensus rating.